HC Wainwright Maintains Buy Rating on AngioDynamics, $18 Target
HC Wainwright maintained its Buy rating on AngioDynamics and a $18.00 price target. The target implies 57.9% upside from the Oct. 12 close of $11.40.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.